PROCAN Drug Patent Profile
✉ Email this page to a colleague
When do Procan patents expire, and when can generic versions of Procan launch?
Procan is a drug marketed by Parke Davis, Parkedale, and King Pharms. and is included in eight NDAs.
The generic ingredient in PROCAN is procainamide hydrochloride. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Procan
A generic version of PROCAN was approved as procainamide hydrochloride by INTL MEDICATION on July 31st, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROCAN?
- What are the global sales for PROCAN?
- What is Average Wholesale Price for PROCAN?
Summary for PROCAN
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Clinical Trials: | 1 |
Patent Applications: | 5,579 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROCAN at DailyMed |
![PROCAN drug patent expirations Drug patent expirations by year for PROCAN](/p/graph/s/t/PROCAN-patent-expirations.png)
Recent Clinical Trials for PROCAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Pittsburgh | N/A |
Evan Adelstein, MD | N/A |
UPMC | N/A |
US Patents and Regulatory Information for PROCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | PROCAN | procainamide hydrochloride | CAPSULE;ORAL | 085804-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Parkedale | PROCAN SR | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 087510-001 | Apr 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Parke Davis | PROCAN SR | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 086468-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |